News

STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN ...
The FDA designates SH-110 as an orphan drug, offering a safer oral treatment option for glioma patients with swallowing ...
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and oxidative stress.
Important near-term catalysts for ETON have been eliminated due to insider stock sales and a disappointing partial FDA ...
STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
Shardul Nautiyal, Mumbai Wednesday, July 16, 2025, 08:00 Hrs [IST] ...
Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...
WHERE IS DEA'S DEPUTY THOMAS PREVOZNIK HIDING?Bright Green Corp: The DEA-Enabled Stock Market Swindle Files For Bankruptcy."Terrance Cole, the nominee for DEA Administrator, must confront this DEA rot ...
AbbVie will be gaining rights to IGI Therapeutics’ lead candidate for oncology and autoimmune diseases in an exclusive ...
RARE faces regulatory setback as FDA issues a CRL for UX111, delaying approval of the MPS IIIA gene therapy until 2026.